From new and exciting case studies to the latest in products and services, our online event will bring together leading industry and academic experts for a day of discussion, knowledge sharing and focused networking sessions.
Theme 1: Design & Development of NK-Based Therapies
Increasing the safety and persistence of allogeneic NK therapies
Genetic modification of NK cells to retarget and sustain anti-tumour activity
In vitro approaches to accelerate off-target effect & toxicity research
Leveraging mechanism of action to elicit stronger & safer therapeutic activity
Optimised analytical approaches tailored to NK-based therapies
Theme 2: Application of NK-Based Therapies
Utilising the most effective strategy for solid tumours
Harnessing NK cell memory for leukaemia immunotherapy
Case studies of NK & CAR-NK clinical trials for haematological malignancies
Strategies for combining NK cells with other agents
Organized by:
Oxford Global
Invited Speakers:
Jan Spanholtz - CSO at Glycostem
Marcela Guzman - Director of Research Development at Sentil Biosciences
Aviad Pata - Head of Research at Gamida Cell
Shawn Cogan - Senior CMC Project Manager at Takeda
Bjorn Onfelt - Professor at KTH Royal Institute of Technology